Omron Healthcare India eyes 45 percent revenue growth in FY 18-19

Published On 2018-01-24 05:06 GMT   |   Update On 2018-01-24 05:06 GMT

New Delhi: Japanese medical devices maker Omron Healthcare is targeting around 45 percent rise in revenues at Rs 189 crore in the next fiscal year aided by expansion in tier-I and tier-II cities.


The company also plans the expansion of sales network and use of e-commerce for promoting its products.


"We are looking at revenues of Rs 189 crore in the fiscal year 2018-19. We are expecting Rs 130 crore in revenues in the current financial year," Omron Healthcare India Pvt Ltd Managing Director Kazunori Tokura told.


"One of the important focus areas for us is geographical expansion across India and we are targeting tier I and tier II cities for this," Tokura said.


The company also plans to expand its retail presence across the country, he added.


"Going forward the company will also enhance interaction with consumers. We will be using both off-line and online mediums for this. We will use e-commerce to grow the business, we will also use it to educate the consumers," he added.


Highlighting the importance of India, Tokura said India is a very important for the company.


When asked if the company had any plans to set up a manufacturing unit in India, he said: "Not in the near future. In the long term, once we achieve a significant volume for our products then we may consider it."


Omron Healthcare product line in the country includes products such as blood pressure monitors, blood glucose monitors, thermometers, nebulizers, respiratory devices and body composition monitors.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News